News|Articles|May 29, 2026

ASCO 2026: Key Genitourinary Oncology Trials to Watch For

Fact checked by: Roman Fabbricatore, Russ Conroy

Saum Ghodoussipour, MD, suggested that advances in liquid biopsy tracking, next-generation ADCs, and organ-sparing approaches may be featured at ASCO 2026.

The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will feature practice-changing clinical data across multiple oncology subspecialties. For genitourinary (GU) oncology clinicians, the upcoming presentations promise to deliver deep discussions on therapeutic sequencing, patient-reported outcomes, and novel mechanistic strategies.